TRANSFORMING ANTIRETROVIRAL THERAPY WITH CUTTING-EDGE DRUG DELIVERY SYSTEMS

Abstract

Novel Drug Delivery Systems (NDDS) have the potential to significantly improve the efficacy of antiretroviral therapy (ART) for HIV/AIDS by enhancing drug bioavailability, targeting, and adherence. NDDS can be designed to improve the solubility and stability of antiretroviral drugs, leading to better absorption and bioavailability as in Nanoparticles and Liposomes which can encapsulate antiretroviral drugs to protect them from degradation and improve their absorption in the gastrointestinal tract. Microspheres which can be used to release drugs slowly over time, maintaining therapeutic drug levels in the body. Targeted Drug Delivery can improve the ART effects where targeting specific tissues or cells can increase the efficacy of antiretroviral drugs and reduce side effects as Nanocarriers where functionalized nanoparticles can target HIV-infected cells or tissues, delivering drugs more directly where they are needed. Another is Conjugated Drugs which can be conjugated with targeting ligands that bind to receptors on HIV-infected cells, enhancing drug uptake by these cells. Controlled or sustained release systems can reduce the frequency of dosing, improving patient adherence as Biodegradable implants can provide long-term drug release, reducing the need for daily medication and Long-acting injectable formulations can maintain effective drug levels in the body for extended periods. NDDS can reduce the number of doses required or combine multiple antiretroviral drugs into a single formulation. NDDS can minimize the side effects associated with antiretroviral therapy by focusing the delivery of drugs to specific cells or tissues, NDDS can reduce systemic exposure and related side effects and by Delivery systems that target the mucosal surfaces (e.g., vaginal or rectal) can potentially reduce systemic toxicity. NDDS can also help manage drug resistance by facilitating the co-delivery of multiple drugs, potentially reducing the risk of resistance by ensuring that multiple antiretroviral agents are present simultaneously and by the systems that allow for high local concentrations of drugs can help in overcoming resistant strains by ensuring effective drug levels are maintained. Emerging technologies in NDDS offer exciting possibilities as Advances in nanotechnology can lead to the development of novel carriers that are more efficient in drug delivery.